Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3
Clinical trial NCT06184503 · RECRUITING
Trial details
- NCT number
- NCT06184503
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-19
- Primary completion
- 2029-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.